Albany, NY -- (SBWIRE) -- 02/10/2017 -- This report covers the market analysis for various diagnostic tests performed to detect hospital associated infections, also called as nosocomial infections. Morbidity rate of nosocomial infections is increasing rapidly worldwide, thereby driving the hospital associated infection (HAI) diagnostic market towards remarkable growth. The stakeholders for this study include manufacturers and providers of diagnostic solutions for nosocomial infections.

For Any Queries Get Solutions With A PDF Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1759

The global hospital acquired disease testing market is categorized on the basis of test types, i.e., urinary tract infection, surgical site infection, pneumonia, blood stream infection, MRSA infection, and others. A detailed market analysis and forecast for these segments has been provided in this study, in terms of market revenue (US$ Mn) for the period 2013 to 2023. The report also provides with the compounded annual growth rate (CAGR %) for each infection type for the forecast period 2015 to 2023, while market size estimations have been made considering 2014 as the base year.

In terms of geographical distribution, the global hospital acquired disease testing market has been classified into four geographical areas: North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The current and future market sizes (in terms of US$ Mn) of the above regional markets have been provided in the report for the period 2013 to 2023 with their growth rate (%) for the period 2015 to 2023. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and grow in the global hospital acquired disease testing market.

The market overview section of the report demonstrates the market dynamics and market trends such as the drivers, restraints and opportunities that influence the current nature and future status of this field. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global hospital acquired disease testing market.

View exclusive Global strategic Business report: http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html

This report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche, Cepheid, Inc., Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/